Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Arbidol in treatment of COVID-19
IRCT20201024049134N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of umifenovir in coronavirus disease 2019 (COVID-19), sponsored by Babol University of Medical Sciences. Started Jan 2021; status: completed.
02
Drugs
umifenovir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201024049134N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201024049134N1.